Bacteriophages cure bacterial infections

Bacteriophages cure bacterial infections

Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant... read more

New Clinical Resources From American Association Of Critical-Care Nurses Address Delirium, CAUTI And VTE

New Clinical Resources From American Association Of Critical-Care Nurses Address Delirium, CAUTI And VTE

Updated AACN Practice Alerts offer latest evidence-based practice related to delirium, catheter-associated urinary tract infections and venous thromboembolism.... read more

Hepatitis B Drug Combination Approved

Hepatitis B Drug Combination Approved

Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.... read more

New Screening Test Identifies Potential Therapies to Fight Drug-Resistant Bacteria

New Screening Test Identifies Potential Therapies to Fight Drug-Resistant Bacteria

Researchers at the NCATS and NIAID have found a new way to identify drugs and drug combinations that may potentially be useful in combating infections that are resistant to antibiotics. The researchers used the test to screen... read more

Ebola adapted to better infect humans during 2013-2016 epidemic

Ebola adapted to better infect humans during 2013-2016 epidemic

Researchers have identified mutations in Ebola virus that emerged during the 2013-2016 Ebola virus epidemic in West Africa that increased the ability of the virus to infect human cells.... read more

Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock

Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock

With a loading dose of 30 mg/kg of amikacin, concentration was potentially suboptimal. The pharmacodynamic target (60 mg/L < C max < 80 mg/L) recommended by French guidelines was reached in 41.8% of patients and was... read more

Metabolic syndrome predicts cardiovascular events in HBV infection

Metabolic syndrome predicts cardiovascular events in HBV infection

Metabolic syndrome was associated with a fourfold rise in cardiovascular events among patients with chronic hepatitis B virus infection, according to a prospective cohort study.... read more

Fatal measles complication more common than thought

Fatal measles complication more common than thought

A deadly complication of measles in young children that strikes years after infection may be more common than previously thought, according to a study presented on Friday that stressed the importance of vaccinations against... read more

Study Links Antibiotic Resistance to Exposure to Chlorhexidine Disinfectants

Study Links Antibiotic Resistance to Exposure to Chlorhexidine Disinfectants

Klebsiella pneumoniae bacteria exposed to chlorhexidine-containing disinfectants can become resistant to colistin, a last-resort antibiotic often used against multidrug-resistant pathogens, according to a study published... read more

Common food additive slows E. coli poisoning

Common food additive slows E. coli poisoning

An additive found in a variety of different foods can slow the effects of E. coli poisoning, Michigan State University researchers found in a study.... read more

Treated bacteremia that clears, then recurs, termed 'skip phenomenon'

Treated bacteremia that clears, then recurs, termed 'skip phenomenon'

About 4% of S. aureus bacteremia cases may not clear completely, as judged by one negative blood culture, contrary to recent IDSA guidelines.... read more

Antibiotics Linked to Sepsis Risk

Antibiotics Linked to Sepsis Risk

Disturbing healthy bacteria during hospital admission associated with later sepsis.... read more

FDA Approves Zinplava to Reduce Recurrence of Clostridium difficile Infection in Adult Patients

FDA Approves Zinplava to Reduce Recurrence of Clostridium difficile Infection in Adult Patients

FDA Approves Merck's ZINPLAVA (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection (CDI) in Adult Patients Receiving Antibacterial Drug Treatment for CDI Who Are at High Risk of CDI Recurrence.... read more

Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens

Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens

Cefiderocol showed potent activity against Gram-negative pathogens, including carbapenem-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii as well as carbapenem-resistant Enterobacteriaceae. The results... read more

Why Many Hospitals Are Banning Flowers and Balloons

Why Many Hospitals Are Banning Flowers and Balloons

Why more hospitals are banning flowers and stuffed animals: Healthcare providers are focused on reducing their rates of HAI (healthcare-acquired infection) and the risk of allergic reaction.... read more

Arkansas mumps outbreak continues to grow, cases near 700

Arkansas mumps outbreak continues to grow, cases near 700

Cases of mumps continue to mount in the ongoing mumps outbreak in northwest Arkansas. The count includes both laboratory confirmed cases and cases currently under investigation. The outbreak has affected more than 30 schools... read more